In all three recurrent MB lines (D425-Re, HD-MB03-Re, and SU_MB002), reduced BPIFB4 expression translated into a reduced tumor burden in both brains and spines (Fig. 5, A to C) and prolonged survival (Fig. 5D). Here, BPIFB4 is linked to neoplasm.